Tag: patent
-
Researcher Studies, Commercializes Nanoscale Drug Delivery
A researcher at University of Alberta in Edmonton, Canada developed a process of delivering drugs to targeted locations in the body with nanoscale polymer capsules, and has received a patent for that process. Afsaneh Lavasanifar, a professor in Alberta’s pharmacy school, also started a company in 2010 to take her process to market. Lavasanifar devised…
-
GE to Crowdsource Product Development from Patent Portfolio
General Electric Company and Quirky, a product development company using social media, are collaborating on developing GE patents into consumer products. The two companies also are partnering on smartphone-enabled apps connecting to useful or important systems in people’s day-to-day lives. Quirky is a social network where inventors and product developers can submit ideas and have…
-
Lab-On-Chip Maker Lands $9.2M in Early Round Venture Funds
Hurel Corporation, a developer of preclinical testing devices in New Brunswick, New Jersey, raised $9.2 million in its first round of venture fund raising after initial start-up. The round was organized by Spring Mountain Capital, a private equity investment management company in New York. No other participants in the round were disclosed. Hurel Corp. designs…
-
Biotech, University to Partner on Bone Regeneration Trial
University of Michigan in Ann Arbor and biotechnology company NeoStem Inc. in New York are collaborating on a clinical trial to test the ability of adult stem cells to grow into bone tissue. The trial, which involves the university’s dental school, will try to regenerate bone tissue among patients who need a tooth extraction. NeoStem…
-
Google: No Open-Source Patent Suits, Microsoft Lists Patents
Information technology giants Google and Microsoft each spelled out new policies yesterday they claim will increase the transparency of their intellectual property practices. Google vowed it would not take legal action against developers of open-source software on some of its patents, and Microsoft published an online tool listing all of the company’s patents. Google’s vow…
-
Patent Granted for Nanotech-Enhanced Biodegradable Polymers
Cereplast Inc., a developer of bio-based plastics in El Segundo, California, received a patent for its process of making biodegradable polymers enhanced with mineral nanoparticles. The U.S. Patent and Trademark Office issued patent number 8,389,614 to Cereplast’s CEO Frederick Scheer and research executive William Kelly, and assigned the patent to Cereplast Inc. on 5 March…
-
Patent Awarded for Lipid Treatments on Lung Infections
A researcher at National Jewish Health, a medical center in Denver, received a patent for methods using naturally occuring lipids to treat infections and inflammation in the lungs. U.S. patent number 8,367,643 was awarded last month to professor of medicine Dennis Voelker and assigned to National Jewish Health. Lipids are oil or fat molecules that…
-
Patent Issued for Drug Technology with Prostate Treatment
Medifocus Inc. in Columbia, Maryland received a patent for a technique of delivering heat-sensitive drugs with its treatment for enlarged prostate. U.S. patent 8,374,702 was awarded to Medifocus chief operating officer John Mon and MIT engineer Alan Fenn on 12 February and assigned to Medifocus. The patent covers a technology for delivering drugs targeted to…
-
FDA Approves Electronic Artificial Retina Implant Device
The U.S. Food and Drug Administration approved the first implant device to restore some visual perception for adults with retinitis pigmentosa, a genetic disease that damages the retina. The Argus II Retinal Prosthesis System is made by Second Sight Medical Products Inc. in Sylmar, California. Retinitis pigmentosa is an eye disease caused by genetic defects…
-
Modeling, Biotechnology Boost Antibiotic Impact on Pathogens
Biomedical engineers at Harvard University’s Wyss Institute for Biologically Inspired Engineering combined computer modeling with biotechnology techniques to weaken resistance of E. coli cells to antibiotics. The team led by Jim Collins, with colleagues from Boston University, published its findings today online in the journal Nature Biotechnology, and filed a U.S. patent for the technology.…